Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details Narrative)

v3.8.0.1
Summary of Significant Accounting Policies (Details Narrative)
3 Months Ended 9 Months Ended
Oct. 23, 2015
USD ($)
Oct. 10, 2014
USD ($)
Payments
shares
Aug. 29, 2014
USD ($)
shares
Jun. 17, 2014
Patents
May 02, 2014
USD ($)
Payments
Integer
shares
Nov. 18, 2013
shares
May 13, 2013
Sep. 30, 2017
USD ($)
Institutions
Sep. 30, 2016
USD ($)
Sep. 30, 2017
USD ($)
Institutions
shares
Sep. 30, 2016
USD ($)
Sep. 29, 2017
$ / shares
Aug. 31, 2017
$ / shares
Dec. 31, 2016
USD ($)
Significant Accounting Policies [Line Items]                            
Number of financial institutions | Institutions               1   1        
Allowance for bad debt               $ 387,976   $ 387,976       $ 387,976
Accounts receivable, net               123,630   123,630       95,069
Prepaid expenses and other current assets               108,878   108,878       202,067
Outstanding litigation bonds                      
Clouding ip earn out liability               754,321   754,321        
Reduction in intangible assets               723,218   723,218        
Impairment of intangible assets               723,218 $ 5,531,383 $ 723,218 $ 6,525,273      
Warrant fair value price per share | $ / shares                       $ 0.0877 $ 0.0364  
Income tax benefit percentage                   50.00%        
Goodwill impairment               0 83,000 $ 0 83,000      
Impairment of long-lived assets                    
Expected forfeiture rate               12.75% 11.03% 12.75% 11.03%      
Compensation expenses               $ 60,115 $ 9,570 $ 108,748 $ 36,832      
Cash and cash equivalents               122,172   122,172       $ 4,998,314
Restricted cash               3,900,000   3,900,000        
Working capital               20,300,000   $ 20,300,000        
Options [Member]                            
Significant Accounting Policies [Line Items]                            
Anti-dilutive securities excluded from computation of diluted shares | shares                   613,195        
Warrant [Member]                            
Significant Accounting Policies [Line Items]                            
Anti-dilutive securities excluded from computation of diluted shares | shares                   7,487,894        
Series B Convertible Preferred Stock [Member]                            
Significant Accounting Policies [Line Items]                            
Anti-dilutive securities excluded from computation of diluted shares | shares                   195,501        
Affiliated Entity [Member] | Dynamic Advances, LLC [Member] | Acquired Intellectual Property [Member]                            
Significant Accounting Policies [Line Items]                            
Ownership interest held         100.00%                  
Number of cash payments made | Payments         2                  
Payments to acquire businesses, net of cash acquired         $ 2,375,000                  
Second payment amount on or before June 30, 2014         $ 2,850,000                  
Preferred stock, shares issued | shares         97,750                  
Maximum possible amount of future payments         $ 250,000,000                  
Affiliated Entity [Member] | Dynamic Advances, IP Liquidity And Sarif Biomedical [Member] | Acquired Intellectual Property [Member]                            
Significant Accounting Policies [Line Items]                            
Number of purchase agreements | Integer         3                  
Affiliated Entity [Member] | IP Liquidity Ventures, LLC [Member] | Acquired Intellectual Property [Member]                            
Significant Accounting Policies [Line Items]                            
Ownership interest held         100.00%                  
Number of cash payments made | Payments         2                  
Payments to acquire businesses, net of cash acquired         $ 2,375,000                  
Second payment amount on or before June 30, 2014         $ 2,850,000                  
Preferred stock, shares issued | shares         97,750                  
Maximum possible amount of future payments         $ 250,000,000                  
Affiliated Entity [Member] | Sarif Biomedical, LLC [Member] | Acquired Intellectual Property [Member]                            
Significant Accounting Policies [Line Items]                            
Ownership interest held         100.00%                  
Number of cash payments made | Payments         2                  
Payments to acquire businesses, net of cash acquired         $ 250,000                  
Second payment amount on or before June 30, 2014         300,000                  
Maximum possible amount of future payments         250,000,000                  
Advisory Services Agreement [Member] | Navigation Group LLC [Member] | Founder And Former Chief Executive Officer [Member]                            
Significant Accounting Policies [Line Items]                            
Length of agreement             9 years              
Feinberg Agreement [Member] | Beneficial Owner [Member] | Trustee [Member] | Restricted Common Stock [Member]                            
Significant Accounting Policies [Line Items]                            
Common stock issued | shares           25,000                
Vesting on first anniversary           50.00%                
Vesting on second anniversary           50.00%                
Feinberg Agreement [Member] | Beneficial Owner [Member] | Trustee [Member] | Restricted Common Stock [Member]                            
Significant Accounting Policies [Line Items]                            
Beneficial ownership percentage           10.00%                
Pay Proceeds Agreement [Member] | Affiliated Entity [Member] | Dynamic Advances, IP Liquidity And Sarif Biomedical [Member] | Acquired Intellectual Property [Member]                            
Significant Accounting Policies [Line Items]                            
Reimbursement revenue         $ 250,000,000                  
Marathon Opportunity Agreement [Member] | Affiliated Entity [Member]                            
Significant Accounting Policies [Line Items]                            
Net recovery proceeds due to sellers         50.00%                  
Number of business days to respond         10 days                  
Merger Agreement [Member] | Selene Communication Technologies, LLC [Member]                            
Significant Accounting Policies [Line Items]                            
Number of patents | Patents       3                    
Patent Purchase Agreement [Member] | Clouding IP, LLC [Member] | Affiliated Entity [Member]                            
Significant Accounting Policies [Line Items]                            
Payments to acquire businesses, net of cash acquired     $ 2,400,000                      
Cash     1,400,000                      
Patent Purchase Agreement [Member] | Clouding IP, LLC [Member] | Affiliated Entity [Member] | Promissory Note [Member]                            
Significant Accounting Policies [Line Items]                            
Promissory note issued     $ 1,000,000                      
Debt maturity date     Oct. 31, 2014                      
Patent Purchase Agreement [Member] | Clouding IP, LLC [Member] | Restricted Common Stock [Member] | Affiliated Entity [Member]                            
Significant Accounting Policies [Line Items]                            
Stock issued in acquisition | shares     6,250                      
Interest Sale Agreement [Member] | MedTech Development, LLC [Member] | Affiliated Entity [Member]                            
Significant Accounting Policies [Line Items]                            
Ownership interest held   45.00%                        
Number of cash payments made | Payments   9                        
Payments to acquire businesses, net of cash acquired $ 100,000 $ 1,000,000                        
Monthly payment obligation   $ 1,000,000                        
Shares granted | shares   500,000                        
Debt extinguishment   $ 654,000                        
Interest Sale Agreement [Member] | MedTech Development, LLC [Member] | MedTech GmbH [Member] | Affiliated Entity [Member]                            
Significant Accounting Policies [Line Items]                            
Percentage of shares   100.00%                        
Interest Sale Agreement [Member] | MedTech Development, LLC [Member] | OrthoPhoenix and TLIF [Member] | Affiliated Entity [Member]                            
Significant Accounting Policies [Line Items]                            
Percentage of shares   100.00%                        
Sales Revenue Net [Member] | License Agreements [Member]                            
Significant Accounting Policies [Line Items]                            
License revenue amount               0 $ 0          
Maximum [Member]                            
Significant Accounting Policies [Line Items]                            
Insured by FDIC               $ 250,000   $ 250,000        
Anti-dilutive securities excluded from computation of diluted shares | shares                   13,750,000        
Maximum [Member] | Advisory Services Agreement [Member] | Navigation Group LLC [Member] | Founder And Former Chief Executive Officer [Member]                            
Significant Accounting Policies [Line Items]                            
Percent of gross proceeds             20.00%              
Maximum [Member] | Pay Proceeds Agreement [Member] | Affiliated Entity [Member] | Dynamic Advances, IP Liquidity And Sarif Biomedical [Member] | Acquired Intellectual Property [Member] | Range Two [Member]                            
Significant Accounting Policies [Line Items]                            
Reimbursement revenue         $ 40,000,000                  
Maximum [Member] | Pay Proceeds Agreement [Member] | Affiliated Entity [Member] | Dynamic Advances, IP Liquidity And Sarif Biomedical [Member] | Acquired Intellectual Property [Member] | Range Three [Member]                            
Significant Accounting Policies [Line Items]                            
Reimbursement revenue         40,000,000                  
Minimum [Member] | Advisory Services Agreement [Member] | Navigation Group LLC [Member] | Founder And Former Chief Executive Officer [Member]                            
Significant Accounting Policies [Line Items]                            
Percent of gross proceeds             10.00%              
Minimum [Member] | Pay Proceeds Agreement [Member] | Affiliated Entity [Member] | Dynamic Advances, IP Liquidity And Sarif Biomedical [Member] | Acquired Intellectual Property [Member] | Range Two [Member]                            
Significant Accounting Policies [Line Items]                            
Reimbursement revenue         13,000,000                  
Range One [Member] | Pay Proceeds Agreement [Member] | Affiliated Entity [Member] | Dynamic Advances, IP Liquidity And Sarif Biomedical [Member] | Acquired Intellectual Property [Member]                            
Significant Accounting Policies [Line Items]                            
Reimbursement revenue         $ 10,000,000                  
Range Two [Member] | Pay Proceeds Agreement [Member] | Affiliated Entity [Member] | Dynamic Advances, IP Liquidity And Sarif Biomedical [Member] | Acquired Intellectual Property [Member]                            
Significant Accounting Policies [Line Items]                            
Net recovery proceeds due to sellers         40.00%                  
Range Three [Member] | Pay Proceeds Agreement [Member] | Affiliated Entity [Member] | Dynamic Advances, IP Liquidity And Sarif Biomedical [Member] | Acquired Intellectual Property [Member]                            
Significant Accounting Policies [Line Items]                            
Net recovery proceeds due to sellers         50.00%                  
Payments of reimbursement revenue         $ 2,400,000